Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AXGN · against 334 other Healthcare companies of similar size
Ranked #249 of 335 · scores higher than 25% of peers
Bars: peers in each 10-point band of the profitability score29 peers with a profitability score of 20–29, including AXGN · Click a bar to see the companies
Mainly because of its return on assets, return on invested capital and operating margin, which are weaker than most Healthcare peers.
| Metric | AXGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 318 reported | -6.3% | 6.9% | 25% | 33% | |
| Operating marginHigher is better · 311 reported | -5.1% | 9.4% | 25% | 33% | |
| Return on assetsHigher is better · 319 reported | -11.0% | 2.4% | 23% | 33% | |
| Return on equityHigher is better · 309 reported | -18.2% | 6.2% | 25% | Context only | |
| Gross marginHigher is better · 342 reported | 74.6% | 48.6% | 82% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 245 | 5.3B USD | 31 | 50 | |
| 245 | 2.2B USD | 31 | 36 | |
| 248 | 2.8B USD | 30 | 33 | |
| 249 | 31.0B CNY (≈$4.3B) | 29 | 26 | |
| 249 | 2.9B USD | 29 | 44 | |
| 249 | 1.8B USD | 29 | 31 | |
| 252 | 15.4B HKD (≈$2.0B) | 28 | 44 | |
| 252 | 1.6B USD | 28 | 48 | |
| 252 | 3.4B USD | 28 | 48 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score